She said that teenage vaccination would be possible to begin in June if the vaccines were approved for use in late May, as scheduled. Vaccine manufacturers then plan to complete clinical trials with children of different ages. On the other hand, the vaccination of younger children could start in the autumn.
“It will certainly be possible both with the family doctor and the vaccination centers and hospitals. (..) At international meetings, I hear that definitely first will be teens and school-age children, and then we will turn to younger children. Let's see. Well, it's probably not a baby vaccination issue,” Zavadska said.
The European Medicines Agency (EMA) has started evaluating the vaccine by Pfizer/BioNTech,which is intended to be used for children aged 12 and up. Canada and the US have already approved the use of this preparation.